+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hisamitsu Pharmaceutical Co Inc (4530) - Product Pipeline Analysis, 2020 Update

FEATURED COMPANIES

  • Daiichi Sankyo Co Ltd
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain relieving products, dermatological products, and quasi drugs, among others. Hisamitsu Pharmaceutical provides its products in various forms: patches, gel-patchs, gels, creams and lotions. Its products are indicated to relieve patients from stiff neck, sore shoulders, arthritis, joint pain backache, strains, sprains, muscle fatigue, bruises, muscle pain, simple backache bruises, stiff shoulders, sprains, strains arthritis, bone fracture, and minor frostbite. It operates production facilities, research laboratories, and offices in Japan. The company markets its products in Asia, Europe, Middle East & Africa, and the Americas. Hisamitsu Pharmaceutical is headquartered in Tosu, Kyushu, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Hisamitsu Pharmaceutical Co Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Daiichi Sankyo Co Ltd
Hisamitsu Pharmaceutical Co Inc Company Overview
  • Hisamitsu Pharmaceutical Co Inc Company Snapshot
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Hisamitsu Pharmaceutical Co Inc - Pipeline Analysis Overview
  • Business Description
  • Hisamitsu Pharmaceutical Co Inc - Key Facts
  • Hisamitsu Pharmaceutical Co Inc - Major Products and Services
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products by Development Stage
Hisamitsu Pharmaceutical Co Inc Pipeline Products Overview
  • ATS Adhesive Skin Patch
  • ATS Adhesive Skin Patch Product Overview
  • Fentos Tape - Pediatrics
  • Fentos Tape - Pediatrics Product Overview
  • HARUROPI TAPE
  • HARUROPI TAPE Product Overview
  • HP-1010 Adhesive Skin Patch
  • HP-1010 Adhesive Skin Patch Product Overview
  • HP-1030 Adhesive Skin Patch
  • HP-1030 Adhesive Skin Patch Product Overview
  • HP-3150 Adhesive Skin Patch
  • HP-3150 Adhesive Skin Patch Product Overview
  • HP-5000 Adhesive Skin Patch
  • HP-5000 Adhesive Skin Patch Product Overview
  • HP-5070 Adhesive Skin Patch
  • HP-5070 Adhesive Skin Patch Product Overview
  • HTU-520 Patch
  • HTU-520 Patch Product Overview
  • Lidocaine Topical Patch
  • Lidocaine Topical Patch Product Overview
Hisamitsu Pharmaceutical Co Inc - Key Competitors

Hisamitsu Pharmaceutical Co Inc - Key Employees
  • Hisamitsu Pharmaceutical Co Inc - Key Employee Biographies
Hisamitsu Pharmaceutical Co Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Recent Developments
  • Hisamitsu Pharmaceutical Co Inc, Recent Developments
  • Dec 16, 2019: Hisamitsu Pharmaceutical: Notification of marketing of HARUROPI TAPE in Japan
  • Nov 28, 2019: Financial support to SAGA Heavy Ion Medical Accelerator in Tosu Project
  • Oct 15, 2019: U.S. FDA approves SECUADO (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the treatment of adults with Schizophrenia
  • Sep 23, 2019: Noven announces appointment of Dr. Naruhito Higo as chief executive officer
  • Sep 20, 2019: Kyowa Kirin announces approval of new transdermal patch HARUROPI TAPE (HP-3000) for Parkinson's Disease in Japan
  • Aug 29, 2019: Kyowa Kirin announces an partial change approval application of FENTOS TAPE (Code: HFT-290) Submission by Hisamitsu Pharmaceutical in Japan
  • Jul 11, 2019: Noven announces appointment of Andrew J. Purcell as head of marketing & sales
  • May 20, 2019: Categorical response and clinical relevance as assessed in a phase III study of HP-3070 (Asenapine) transdermal patch for the treatment of schizophrenia to be presented at the American Psychiatric Association 172nd Annual Meeting
  • Dec 14, 2018: Notification of the results of phase III clinical study in Opioid Analgesic NaiVe patients of the Transdermal, Pain Management Patch FENTOSTAPE (Development Code:HFT-290)
  • Oct 22, 2018: Notification of the commencement of the phase II clinical study of HP-5070 in Japan (A transdermal drug for the treatment of primary local hyperhidrosis)
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products by Equipment Type
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products by Indication
  • Hisamitsu Pharmaceutical Co Inc, Key Facts
  • Hisamitsu Pharmaceutical Co Inc, Major Products and Services
  • Hisamitsu Pharmaceutical Co Inc Number of Pipeline Products by Development Stage
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products Summary by Development Stage
  • ATS Adhesive Skin Patch - Product Status
  • ATS Adhesive Skin Patch - Product Description
  • Fentos Tape - Pediatrics - Product Status
  • Fentos Tape - Pediatrics - Product Description
  • HARUROPI TAPE - Product Status
  • HARUROPI TAPE - Product Description
  • HP-1010 Adhesive Skin Patch - Product Status
  • HP-1010 Adhesive Skin Patch - Product Description
  • HP-1030 Adhesive Skin Patch - Product Status
  • HP-1030 Adhesive Skin Patch - Product Description
  • HP-3150 Adhesive Skin Patch - Product Status
  • HP-3150 Adhesive Skin Patch - Product Description
  • HP-5000 Adhesive Skin Patch - Product Status
  • HP-5000 Adhesive Skin Patch - Product Description
  • HP-5070 Adhesive Skin Patch - Product Status
  • HP-5070 Adhesive Skin Patch - Product Description
  • HTU-520 Patch - Product Status
  • HTU-520 Patch - Product Description
  • Lidocaine Topical Patch - Product Status
  • Lidocaine Topical Patch - Product Description
  • Hisamitsu Pharmaceutical Co Inc, Key Employees
  • Hisamitsu Pharmaceutical Co Inc, Key Employee Biographies
  • Hisamitsu Pharmaceutical Co Inc, Other Locations
  • Hisamitsu Pharmaceutical Co Inc, Subsidiaries
  • Hisamitsu Pharmaceutical Co Inc, Joint Venture
  • Glossary
List of Figures
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products by Equipment Type
  • Hisamitsu Pharmaceutical Co Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Zeria Pharmaceutical Co Ltd
  • Teva Pharmaceutical Industries Ltd
  • SymBio Pharmaceuticals Ltd
  • Kaken Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • AFC-HD AMS Life Science Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll